RATIONALE OF A PHASE-III STUDY COMPARING A STANDARD CISPLATIN REGIMEN(MITOMYCIN IFOSFAMIDE/CISPLATIN) WITH CISPLATIN AND GEMCITABINE IN NONSMALL CELL LUNG-CANCER/

Authors
TONATO M CRINO L MOSCONI AM
Citation
M. Tonato et al., RATIONALE OF A PHASE-III STUDY COMPARING A STANDARD CISPLATIN REGIMEN(MITOMYCIN IFOSFAMIDE/CISPLATIN) WITH CISPLATIN AND GEMCITABINE IN NONSMALL CELL LUNG-CANCER/, Seminars in oncology, 24(3), 1997, pp. 831-835
Citations number
19
Categorie Soggetti
Oncology
Journal title
Seminars in oncology → ACNP
ISSN journal
00937754
Volume
24
Issue
3
Year of publication
1997
Supplement
8
Pages
831 - 835
Database
ISI
SICI code
0093-7754(1997)24:3<831:ROAPSC>2.0.ZU;2-X